David Walcott: Blood Supply as Essential Healthcare Infrastructure
David Walcott, Co-Managing Partner at Novamed Ventures, shared World Health Organization‘s post on LinkedIn:
“Blood systems are increasingly being understood not just as a hospital resource, but as critical national infrastructure that underpins modern healthcare.
Awareness efforts from the World Health Organization highlight the essential role that blood and plasma donations play across a wide range of medical conditions – from childbirth complications and trauma to cancer treatment, bleeding disorders, immune deficiencies, and chronic diseases.
What’s striking is how many aspects of healthcare depend on a reliable blood supply.
Unlike many medical products, blood cannot be manufactured at scale, making voluntary donation one of the few healthcare resources that depends directly on community participation.
That’s why health systems increasingly focus on strengthening blood collection, testing, storage, and distribution networks.
Safe and timely access to blood products is a prerequisite for effective emergency care, surgery, maternal health services, oncology treatment, and many other essential health interventions.
The implication is that resilient healthcare systems require more than hospitals, medicines, and healthcare workers – they also require sustainable donation ecosystems capable of meeting ongoing demand.
If blood donation rates remain strong and blood services continue to improve, millions of patients worldwide will have access to life-saving treatments that would otherwise be unavailable, demonstrating how individual acts of contribution can create profound public health impact.”
World Health Organization shared a post on LinkedIn:
“Chronic blood conditions.
Childbirth complications.
Cancer treatment.
Bleeding disorders.
Immune deficiencies.
Safe blood and plasma donations provide a critical lifeline for patients facing these and many other life-threatening conditions.
Everyone everywhere should have timely access to safe blood and blood products.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause